Vol 8, No 2 (April 2019): Hepatobiliary Surgery and Nutrition (Special Focus on Antibodies and Liver Transplantation: Part 2)

Original Article

Association of family history with long-term prognosis in patients undergoing liver resection of HBV-related hepatocellular carcinoma
Zhen-Li Li, Jun Han, Kai Liu, Hao Xing, Han Wu, Wan Yee Lau, Timothy M. Pawlik, Chao Li, Ming-Da Wang, Jiong-Jie Yu, Meng-Chao Wu, Feng Shen, Tian Yang
The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures
Vinzent N. Spetzler, Marlene Schepers, Hans O. Pinnschmidt, Lutz Fischer, Björn Nashan, Jun Li
The 3-60 criteria challenge established predictors of postoperative mortality and enable timely therapeutic intervention after liver resection
Georg P. Gyoeri, David Pereyra, Eva Braunwarth, Markus Ammann, Philipp Jonas, Florian Offensperger, Florian Klinglmueller, Ruth Baumgartner, Sandra Holzer, Michael Gnant, Friedrich Laengle, Stefan Staettner, Thomas Gruenberger, Patrick Starlinger

Special Issue: Antibodies and Liver Transplantation, Guest-Edited by Prof. Vivian McAlister

Anti-donor immunoglobulin G subclass in liver transplantation
Vivian C. McAlister

Review Article

Surgical treatment of ovarian cancer liver metastasis
Miao Wang, Jiamin Zhou, Lyu Zhang, Yiming Zhao, Ning Zhang, Longrong Wang, Weiping Zhu, Xigan He, Hongxu Zhu, Weiqi Xu, Qi Pan, Anrong Mao, Qinchuan Li, Lu Wang


A promising ex vivo liver protection strategy: machine perfusion and repair
Junjun Jia, Jianhui Li, Shiyu Zhang, Haiyang Xie, Lin Zhou, Shusen Zheng
Sarcopenia and nonalcoholic fatty liver disease: a causal relationship
Lucia Pacifico, Francesco Massimo Perla, Claudio Chiesa
Is there a real survival benefit of surveillance for hepatocellular carcinoma in cirrhotic patients?
Massimo Colombo, Ana Lleo
Surgery for hepatocellular carcinoma can provide the same life-expectancy as transplant of that of general population
Giorgio Ercolani, Michele Cucchi
Cabozantinib for advanced hepatocellular carcinoma
Masatoshi Kudo
Edible hybrid microbial-electronic sensors for bleeding detection and beyond
Christopher J. Bettinger
Improving actual survival after hepatectomy for intrahepatic cholangiocarcinoma—still a long way to go
Alexandre Doussot, William R. Jarnagin, Daniel Azoulay, Bruno Heyd
Nonalcoholic fatty liver disease: does sex matter?
Amedeo Lonardo, Ayako Suzuki
Nonalcoholic fatty liver disease (NAFLD) prevention: role of Mediterranean diet and physical activity
Francesca Maria Trovato, Paola Castrogiovanni, Lorenzo Malatino, Giuseppe Musumeci
Nonalcoholic fatty liver disease with advanced fibrosis as a multi-systemic disease: proceed with caution
Masato Yoneda, Yuji Ogawa, Kento Imajo, Atsushi Nakajima
Building mass to prevent non-alcoholic fatty liver disease?
Serena Pelusi, Luca Valenti

Special Issue: Antibodies and Liver Transplantation, Guest-Edited by Prof. Vivian McAlister

Fatal graft versus host hemolytic reaction from Rhesus compatible mismatched liver transplantation
Hemant Sharma, Vivian McAlister
Long term follow-up after liver transplantation from a JAK2 mutation positive donor
Alejandro Lazo-Langner, Peter Ainsworth, Vivian McAlister